Tedizolid

Overview

Tedizolid is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1257051).

API suppliers (2)

Suppliers of Tedizolid evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• NANJING YOKO PHARMACEUTICAL CO LTD1 active DMF
• YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTDChina1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Tedizolid expires 31 Dec 2030 and exclusivity 4 Apr 2028. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(5R)-3-[3-fluoro-4-[6-(2-methyltetrazol-5-yl)-3-pyridinyl]phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one

Canonical SMILES

CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4C[C@@H](OC4=O)CO)F

InChIKey

XFALPSLJIHVRKE-GFCCVEGCSA-N